Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. hyscreen

HYscreen

A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 HYscreen project word cloud

Explore the words cloud of the HYscreen project. It provides you a very rough idea of what is the project "HYscreen" about.

mouthpiece    infection    primary    global    monitoring    bedfont    respectively    diagnostics    give    diagnostic    final    biopsies    realized    impetus    portable    bill    convenience    device    biomarker    innovation    scientific    savings    reduce    ltd    cancer    protection    sampling    market    breath    offers    optimizing    costly    solutions    though    asia    too    expensive    nitrogen    treatment    thermal    invasive    secondary    c12    ammonia    quicker    solution    decisions    ulceration    close    plan    tests    ulcers    unnecessary    incidence    exhaled    simpler    commercially    rapid    detects    clinical    oxidizer    doors    screening    inconvenient    infections    air    lower    expertise    healthcare    ultimately    answering    urea    trials    pylori    link    gastric    endoscopies    prototype    business    feasibility    care    oxide    preventing    programs    shorten    time    billion    simplicity    diagnosis    affordable    absorption    entrapment    lymphoma    population    cheaper    validation    accuracy    hyscreen    helicobacter    optimization    sensor    duodenal    avoiding    fast    consequently    usa    66    aesthetics   

Project "HYscreen" data sheet

The following table provides information about the project.

Coordinator		 Bedfont Scientific Limited 

Organization address
address: Station Yard, Station Road
city: Maidstone
postcode: ME17 1JA
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Project website https://www.bedfont.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Bedfont Scientific Limited UK (Maidstone) coordinator 50˙000.00

Map

 Project objective

The increasing incidence of Helicobacter (H.) pylori infections and their close link with gastric cancer, gastric lymphoma, duodenal and gastric ulceration, give impetus to the H. pylori diagnostics market. Existing solutions are too costly, inconvenient and invasive; have a long analysis time or need technical expertise to analyse. Bedfont Scientific Ltd offers a portable H. pylori diagnostic device, HYscreen, which detects ammonia in exhaled air as a biomarker for H. pylori. It has a rapid diagnosis, higher accuracy, lower cost, greater simplicity and convenience. It has the following innovation features: a mouthpiece breath entrapment sampling system, a thermal oxidizer and a Nitrogen Oxide (NO) sensor. This solution is aimed at primary and secondary care in Europe and USA and population screening programs in Asia, answering the call for a cheaper, quicker and simpler monitoring device. This will lead to improved clinical decisions that will facilitate early treatment of the infection, preventing H pylori related cases of gastric cancer and gastric or duodenal ulcers. Consequently, Europe-wide and global savings of up to €1.5 billion and €5.66 billion respectively will be realized by avoiding unnecessary endoscopies, biopsies, expensive H. pylori tests and the healthcare bill from H. pylori-related conditions. Ultimately, HYscreen will open doors for fast and affordable population wide screening. The test will use cheaper C12 urea, though work still needs to be done to make it commercially available. There is a challenge to shorten the thermal oxidizer system for better aesthetics and to reduce ammonia absorption. In Phase 1, we study the feasibility of optimizing the thermal oxidizer system, the use and optimization of C12 urea, protection of the product and the detailed business plan. Phase 2 will produce the final product from the prototype along with the validation steps and clinical trials.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More